Skip to main content
. 2022 Feb 14;6(4):1162–1174. doi: 10.1182/bloodadvances.2021006043

Figure 1.

Figure 1.

Clinical response in evaluable patients at C3D28, C5D28, week 32, and C11 day 28. (A) Patients with hematocrit (Hct) control. (B) Patients who showed response according to the ELN hematologic response criteria. (C) Patients with CHR (C) or composite response (D). CR, complete remission; PR, partial remission.